P3 Health Partners (PIII) Reaffirms Guidance For 2022, Issues 2023 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023
January 11, 2023 4:01 PM ESTHENDERSON, Nev.--(BUSINESS WIRE)-- P3 Health Partners Inc. (P3 or the Company) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is participating in J.P. Morgans 41st Annual Healthcare Conference, being held in San Francisco, CA from January 9-12, 2023. In advance of the associated presentation, P3 is reaffirming full-year 2022 financial guidance and announcing financial guidance for... More
